Assessment of a novel VEGF targeted agent using patient-derived tumor tissue xenograft models of colon carcinoma with lymphatic and hepatic metastases.
The lack of appropriate tumor models of primary tumors and corresponding metastases that can reliably predict for response to anticancer agents remains a major deficiency in the clinical practice of cancer therapy. It was the aim of our study to establish patient-derived tumor tissue (PDTT) xenograf...
Main Authors: | Ketao Jin, Guangliang Li, Binbin Cui, Jing Zhang, Huanrong Lan, Na Han, Bojian Xie, Feilin Cao, Kuifeng He, Haohao Wang, Zhenzhen Xu, Lisong Teng, Tieming Zhu |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3229582?pdf=render |
Similar Items
-
Patient-derived xenograft models for gastrointestinal tumors: A single-center retrospective study
by: Xiongfei Yu, et al.
Published: (2022-11-01) -
Equine ovarian tissue xenografting: impacts of cooling, vitrification, and VEGF
by: Samara Silva Souza, et al.
Published: (2021-10-01) -
VEGF-C promotes the development of lymphatics in bone and bone loss
by: Devon Hominick, et al.
Published: (2018-04-01) -
Telocytes and Lymphatics of the Human Colon
by: Mihai Zurzu, et al.
Published: (2021-09-01) -
VEGF-D promotes the metastatic spread of tumor cells via the lymphatics.
by: Stacker, SA, et al.
Published: (2001)